Zenas BioPharma, Inc.

General ticker "ZBIO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.1B (TTM average)

Zenas BioPharma, Inc. follows the US Stock Market performance with the rate: 10.3%.

Estimated limits based on current volatility of 3.6%: low 27.42$, high 29.50$

Factors to consider:

  • Total employees count: 130 as of 2024
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: No approved products, Significant losses, Regulatory and compliance, Clinical trial failure, Need for additional capital
  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [16.75$, 50.11$]
  • 2026-12-31 to 2027-12-31 estimated range: [8.96$, 29.17$]

Similar symbols

Short-term ZBIO quotes

Long-term ZBIO plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $50.00MM $5.00MM $10.00MM
Operating Expenses $87.15MM $168.89MM $393.06MM
Operating Income $-37.15MM $-163.89MM $-383.06MM
Non-Operating Income $0.32MM $7.33MM $5.24MM
Interest Expense $0.00MM $0.00MM $7.33MM
R&D Expense $70.03MM $139.14MM $339.74MM
Income(Loss) $-36.82MM $-156.56MM $-377.82MM
Taxes $0.30MM $0.43MM $-0.08MM
Net Income(Loss)* $-37.12MM $-156.99MM $-377.74MM
Stockholders Equity $-225.72MM $312.46MM $242.14MM
Assets $68.18MM $369.97MM $383.64MM
Operating Cash Flow $-30.53MM $-119.67MM $-172.33MM
Capital expenditure $0.02MM $0.13MM $0.02MM
Investing Cash Flow $-0.02MM $-30.55MM $-251.89MM
Financing Cash Flow $20.12MM $412.96MM $215.28MM
Earnings Per Share** $-0.97 $-3.76 $-8.44

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.